Bristol-Myers Squibb is planning to launch 8 drugs in 18 months for everything from cancer to multiple sclerosis. Here's what they are and how the $150 billion pharma giant plans to pull it off.

Advertisement
Bristol-Myers Squibb is planning to launch 8 drugs in 18 months for everything from cancer to multiple sclerosis. Here's what they are and how the $150 billion pharma giant plans to pull it off.
Bristol-Myers Squibb CEO Giovanni Caforio

Getty Images

Advertisement

Bristol-Myers Squibb CEO Giovanni Caforio

  • The newly combined Bristol-Myers Squibb and Celgene is shaping up to be a formidable company in the pharmaceutical industry.
  • It's now looking at eight upcoming drug launches over the next 12 to 18 months, Bristol-Myers Squibb chief commercial officer Chris Boerner told Business Insider.
  • From treatments that use the body's cells to fight cancer to potential treatments for multiple sclerosis and psoriasis, here's what's ahead for the pharma giant.
  • Click here for more BI Prime stories.

When Bristol-Myers Squibb picked up biotech giant Celgene in a deal valued at $74 billion, it formed a formidable company that could become the biggest cancer drugmaker in the world.

As a combined company it has the benefit of owning two sets of treatments that have been developed for various diseases, some of which are on the cusp of getting approval.

That's teeing BMS up for potentially eight drug launches over the next 12 to 18 months, Chris Boerner, BMS chief commercial officer told Business Insider. To get there, the Food and Drug Administration will have to vet how effective and safe each of the treatments are.

Advertisement

"This is almost an unprecedented set of opportunities for us," Boerner said.

Chris Boerner '16 29

Bristol-Myers Squibb

Bristol-Myers Squibb chief commercial officer Chris Boerner

The launches include expanding some of the uses for treatments like BMS's cancer immunotherapy combination Opdivo and Yervoy, as well as some cutting-edge cell therapy treatments for cancer and a treatment for relapsing multiple sclerosis.

Here are the 8 launches BMS hopes to have within the next 18 months

Digital Health Pro

Advertisement

Featured Digital Health Articles:
- Telehealth Industry: Benefits, Services & Examples
- Value-Based Care Model: Pay-for-Performance Healthcare
- Senior Care & Assisted Living Market Trends
- Smart Medical Devices: Wearable Tech in Healthcare
- AI in Healthcare
- Remote Patient Monitoring Industry: Devices & Market Trends

NOW WATCH: This animation shows how far your sneeze can actually travel

{{}}